GNIPST Bulletin Vol:20, Issue:04

7/30/2019 GNIPST Bulletin Vol:20, Issue:04

1/14

1

1118-1177-4796-9849-7562-5062mail

GNIPST BULLETIN 2012

14th

December 2012 Volume No.: 20 Issue No.: 0

Contents Message from GNIPS

Letter to the Editor News Update

Disease Outbreak Ne

Health Awareness

Forth Coming Events

Drugs Update

Campus News

Students Section

Editors Note

Archive

Vision

TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O

PHARMACEUTICAL AND BIOLOGICAL SCIENCE

EDITOR: Debabrata Ghosh DastidarGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND

TECHNOLOGY

GNIPST Photo Gallery

For your comments/contribution

ack-Issues,

mailto:[email protected]
https://picasaweb.google.com/111714720327580099858/FreshersWelcome20122012mailto:[email protected]:[email protected]:[email protected]://picasaweb.google.com/111714720327580099858/FreshersWelcome20122012


2/14

14-12-2012

Click here to go at the top

MESSAGE FROM GNIPST

All the members of GNIPST are proud to publish the 20th

Volume

of GNIPST BULLETIN. This bulletin has successfully

completed its twenty months journey. We hope it has kept the

readers updated of recent activities in pharmaceutical & biological

sciences and also introduced them with the different activities of

our esteemed institution. We are thankful to all of you for your

great cooperation & support and are looking forward to the samein

future.

LETTER TO THE EDITOR.

NEWS UPDATE

Human Rights Day: 10thDecember, 2012

On 10 December 1948, the UN General Assembly adopted the

Universal Declaration of Human Rights, which has become a

universal standard for the promotion and protection of human

rights worldwide.

This year on 10 December, the international community celebrates

Human Rights Day to mark the adoption of the UniversalDeclaration.

1
http://www.who.int/mediacentre/factsheets/fs323/en/index.htmlhttp://www.who.int/mediacentre/factsheets/fs323/en/index.htmlhttp://www.who.int/mediacentre/factsheets/fs323/en/index.html


3/14

14-12-2012


Researchers Develop Novel 3-D Culture System

for Inflammatory Breast Cancer

(08 DECEMBER 2012)

Inflammatory breast cancer is a very rare and aggressive disease.

To understand how this type of cancer spreads, it's crucial to

characterize the interactions between cancer cells and their 3-D

environment. Researchers have developed a novel, 3-D culture

system that mimics the environment surrounding these cancer

cells. This model could be used to test new anticancer drugscapable of inhibiting the spread of IBC tumors.

Pre-Clinical Data Suggests Effective

Against Leukemia(09 DECEMBER 2012)

Angiocidin, a novel tumor-inhibiting protein, has been shown to

reduce acute myeloid leukemia (AML) cells in vivo by almost two-

thirds in pre-clinical experiments.

Brain Displays an Intrinsic Mechanism for

Fighting Infection(10 DECEMBER 2012)

White blood cells have long reigned as the heroes of the immunesystem. When an infection strikes, the cells, produced in bone

marrow, race through the blood to fight off the pathogen. But new

research is emerging that individual organs can also play a role in

2
http://www.sciencedaily.com/releases/2012/12/121208122703.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121208122703.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121209152523.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121209152523.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121209152523.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121208122703.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


4/14

14-12-2012


immune system defense, essentially being their own hero. In a

study examining a rare and deadly brain infection, scientists have

found that the brain cells of healthy people likely produce their

own immune system molecules, demonstrating an "intrinsic

immunity" that is crucial for stopping an infection.

Biologists Engineer Algae to Make Complex

Anti-Cancer 'Designer' Drug? (10 DECEMBER 2012)

Biologists have succeeded in genetically engineering algae to

produce a complex and expensive human therapeutic drug used to

treat cancer. Their achievement opens the door for making these

and other "designer" proteins in larger quantities and much more

cheaply than can now be made from mammalian cells.

Does Changing the Price of Medicine Influence

Consumers' Perceived Health Risk?

(11 DECEMBER 2012)

Consumers assume their risk of getting a serious illness is higher

when medications are cheaper because they believe that prices for

life-saving products are based on need and not profit, according toa new study.

3
http://www.sciencedaily.com/releases/2012/12/121210221259.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121210221259.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121210160846.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121210160846.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121211130323.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121211130323.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121211130323.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121211130323.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121210160846.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121210221259.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


5/14

14-12-2012


Got Food Allergies? You Can Now Test Your

Meal On the Spot Using a Cell Phone

(12 DECEMBER 2012)

Scientists have developed a lightweight device called the iTube,

which attaches to a common cell phone to detect allergens in food

samples. The iTube attachment uses the cell phone's built-in

camera, along with an accompanying smart-phone application

that runs a test with the same high level of sensitivity a laboratorywould.

'Smart Stethoscope' Advance in Monitoring

Treatment of Kidney Stones (12 DECEMBER 2012)

A new listening device is being used to monitor the effectiveness of

the treatment of kidney stones -- saving patients unnecessary

repeat therapy and x-ray monitoring. The new 'Smart stethoscope'

is placed on a patient's skin as they undergo shock wave treatment

for kidney stones and assesses whether the treatment is working.

4
http://www.sciencedaily.com/releases/2012/12/121212205920.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121212092815.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121212205920.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


6/14

14-12-2012


Study Paves Way to Design Drugs Aimed at

Multiple Protein Targets at Once

(12 DECEMBER 2012)

Pharmaceutical chemists had suggested that the objective of a

drug hitting multiple targets simultaneously is impossible and

unlikely to succeed. A new study shows how to efficiently and

effectively make designer drugs that can do that.

Targeted Micro-Bubbles Detect Artery

Inflammation: Procedure Done in Pigs Could

Potentially Detect Heart Disease Early in

Humans (12 DECEMBER 2012)

Researchers have found that targeted micro-bubbles can help

detect heart disease before it progresses too far as well as identify

patients who are at risk for strokes.

5
http://www.sciencedaily.com/releases/2012/12/121212134058.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121212134215.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121212134215.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121212134215.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121212134058.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


7/14

14-12-2012


HEALTH AWARENESS

Health and Human Right

The does not mean the right to be healthy, nor does it mean that poorgovernments must put in place expensive health services for which they have no

resources. But it does require governments and public authorities to put in place

policies and action plans which will lead to available and accessible health care for all

in the shortest possible time. To ensure that this happens is the challenge facing both

the human rights community and public health professionals.

United Nations High Commissioner

for Human Rights, Mary Robinson

6


8/14

14-12-2012


DISEASE OUTBREAK NEWS

Yellow fever in the Republic of Congo

(12 DECEMBER 2012)

The Ministry of Health of the Republic of Congo is launching an

emergency mass-vaccination campaign against yellow fever in Ewo

District in Cuvette-Ouest region, beginning next week.

FORTHCOMING EVENTS

There is a short-term (2 weeks) AICTE sponsored refresher course

for teaching staffs of the Indian Universities and colleges on:

Directions of Pharma-Research to achieve Pharma-excellence

by 2025.

Duration of the Course: 8th January 2013 to 21st January 2013.Venue: Seminar room, 3rd floor, Dept. of Pharm. Tech., JU

Interested participants may apply on plain paper through their

Head of the Institution or Colleges giving full details of their name,

address with e-mail, qualifications, teaching & research

rxperiences with an attested photograph pasted on it, to Dr.Biswajit Mukherjee, Coordinator, QIP Nodal Cell (Pharmacy),

Department of Pharmaceutical Technology, Jadavpur University,

Kolkata-700032 on or before 20th December, 2012. TA and DA will

be provided as per the AICTE Rules.

7
http://www.who.int/csr/don/2012_12_12/en/index.htmlhttp://www.who.int/csr/don/2012_12_12/en/index.html


9/14

14-12-2012


DRUGS UPDATES

FDA approves to treat two rare types of

leukemia (14 DECEMBER 2012)The U.S. Food and Drug Administration approved

( ) to treat adults with chronic myeloid leukemia (CML)

and Philadelphia chromosome positive acute lymphoblastic

leukemia, two rare blood and bone marrow diseases.

FDA approves raxibacumab to treat inhalational

anthrax (14 DECEMBER 2012)

The U.S. Food and Drug Administration approved raxibacumab

injection to treat inhalational anthrax, a form of the infectious

disease caused by breathing in the spores of the bacterium Bacillus

anthracis.

FDA approves Signifor, a new orphan drug for

Cushings disease (14 DECEMBER 2012)

The U.S. Food and Drug Administration approved Signifor

(pasireotide diaspartate) injection for the treatment of Cushings

disease patients who cannot be helped through surgery.

8
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332252.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332341.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332351.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332351.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332341.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332252.htm


10/14

14-12-2012


CAMPUS NEWS

AICTE has sanctioned a release of grant under Research

Promotion Scheme (RPS) during the financial year 2012-13

to GNIPST as per the details below:

a. Beneficiary Institution: Guru Nanak Institution of

Pharmaceutical Science & Technology.

b. Principal Investigator: Dr. Lopamudra Dutta.

c. Grant-in-aid sanctioned: Rs. 16,25000/- only

d.Approved duration: 3 years

e. Title of the project: Screening and identification of

potential medicinal plant ofPurulia & Bankura districts of West

Bengal with respect to diseases such as diabetes, rheumatism,

Jaundice, hypertension and developing biotechnological tools for

enhancing bioactive molecules in these plant.Special classes on Communication Skills, G.D. and Interview

will commence from 3rd week of January 2013 for the

students of this Institute. Interested students are required to

contact the undersigned for enrolment either personally or by

e-mail.

Dr. Lopamudra Datta

E-mail: [email protected]

[email protected]

9
mailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]


11/14

14-12-2012


STUDENTS SECTION

WHO CAN ANSWER FIRST???

() Which biological inhibitor was first isolated by in 1976?

() Which drug was initially designated as MK-733?

A) NOKIA B)Rene Higuita

[email protected]

EDITORS NOTE

I am very happy to publish the 4th

issue of 20th

Volume of GNIPST

BULLETIN. It is my great pleasure to introduce you to the newly

launched facebook account GNIPST bulletin. You are cordially

invited to add this account to your friend list. From this current issue

this bulletin will also be directly available on facebook.

I would like to convey my thanks to all the GNIPST members and

the readers for their valuable comments, encouragement& supports.

10
mailto:[email protected]:[email protected]:[email protected]


12/14

14-12-2012


Special thanks to Dr. Prerona Saha for her advice; Mr. Soumya

Bhattacharya, for his contribution in students section.

It would be my great pleasure to receive the contributions,

suggestions & feedback from your desk for further upliftment of this

deliberation GNIPST BULLETIN.

ARCHIVE

The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15th June, 2012. The programme started

with a nice presentation by Dr. Pulok Kr. Mukherjee, School of

Natural Products, JU on the skill to write a good manuscript for

publication in impact journals. It was followed by nearly two hour

long discussion among more than thirty participants on different

aspects of pharmacy education. Five nonmember participants

applied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm) in

The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to120.

11


13/14

14-12-2012


2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals),

Molecular Imaging (PET/CT), Targeted Radionuclide Therapy, and

Dosimetry (SWC-2013) : On the Way to Personalized Medicine

Dates 28 Feb 2013 02 Mar 2013

Location: Chandigarh, India.

5-Days Hands-on Workshop on Molecular Biotechnology and Bioinformatics.

7

th

to 11

th

January 2013, Pune, Maharashtra, India.

IAMLE- 2013 4th International Conference on Medical Negligence and

litigation in Medical Practice, and 4th International Conference on Recent

Advances in Forensic Sciences, Forensic Medicine & Toxicology.

Date: 25 Jan 2013 27 Jan 2013, Location: Kovalam, Thiruvanthapuram,

India.

will be held

from , at Chennai. The four-day event

will be organized by the Association of Pharmacy Teachers of India

(APTI).

45th Annual Conference of Indian pharmacological Society &

International Conference on

12
http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.icsccb.org/workshops/http://www.icsccb.org/workshops/http://www.iamleconf.in/homehttp://www.iamleconf.in/homehttp://www.iamleconf.in/homehttp://www.icsccb.org/workshops/http://www.2ndworldcongress-ga-68.de/


14/14

14-12-2012


will be organized at on

Jan 05-07, 2013.

For further detail, visit:http://www.ipsnagpur2012.org/InternalPage.aspx

13
http://www.ipsnagpur2012.org/InternalPage.aspxhttp://www.ipsnagpur2012.org/InternalPage.aspxhttp://www.ipsnagpur2012.org/InternalPage.aspxhttp://www.ipsnagpur2012.org/InternalPage.aspx

Date post:	04-Apr-2018
Category:	Documents
Upload:	gnipst-bulletin
View:	223 times
Download:	0 times

GNIPST Bulletin Vol:20, Issue:04

Documents